Showing results 21 to 40 of 41
< previous
next >
| Issue Date | Title | Author(s) |
| 2014-01-01 | Effect of pharmaceutical intervention on medication adherence and blood pressure control in treated hypertensive patients: Rationale, design and methods of the AFenPA pilot study | Fikri-Benbrahim, N; Sabater-Hernández, D; Fikri-Benbrahim, O; Faus, MJ; Martínez-Martínez, F; González-Segura Alsina, D |
| 2014-01 | Development of a theoretically based implementation protocol. | Moullin, J; Sabater-Hernández, D; Benrimoj, S |
| 2013-11-21 | Pharmaceutical care publication | Sabater-Hernández, D |
| 2013-11-21 | Investigation in indigenous development and provision of pharmaceutical care: A comprehensive | Sabater-Hernández, D |
| 2013-11-01 | Impact of a community pharmacists' hypertension-care service on medication adherence. The AFenPA study | Fikri-Benbrahim, N; Faus, MJ; Martínez-Martínez, F; Sabater-Hernández, D |
| 2013-11-01 | Defining professional pharmacy services in community pharmacy | Moullin, JC; Sabater-Hernández, D; Fernandez-Llimos, F; Benrimoj, SI |
| 2013-09-01 | Effect of a pharmacist intervention on asthma control. A cluster randomised trial | García-Cárdenas, V; Sabater-Hernández, D; Kenny, P; Martínez-Martínez, F; Faus, MJ; Benrimoj, SI |
| 2012-08-01 | Terms used in patient safety related to medication: A literature review | Pintor-Mármol, A; Baena, MI; Fajardo, PC; Sabater-Hernández, D; Sáez-Benito, L; García-Cárdenas, MV; Fikri-Benbrahim, N; Azpilicueta, I; Faus, MJ |
| 2012-08-01 | Effect of a pharmacist intervention in Spanish community pharmacies on blood pressure control in hypertensive patients | Fikri-Benbrahim, N; Faus, MJ; Martínez-Martínez, F; Alsina, DGS; Sabater-Hernández, D |
| 2012-05-01 | Study of compliance with prescription information sheet of trastuzumab prescriptions in a tertiary level hospital | Vargas-Rivas, JE; Montes-Casas, MM; Cancela-Diez, B; Martínez-Martínez, F; Sabater-Hernández, D; Calleja-Hernández, MA |
| 2012-04-01 | Agreement Between Community Pharmacy and Ambulatory and Home Blood Pressure Measurement Methods to Assess the Effectiveness of Antihypertensive Treatment: The MEPAFAR Study | Sabater-Hernández, D; De La Sierra, A; Sánchez-Villegas, P; Santana-Pérez, FM; Merino-Barber, L; Faus, MJ; Muñoz, PA; Parejo, MIB; Peña, NEH; Díaz, JMS; Campelo, AA; Jorge Rodríguez, ME; García Morales, MF; Merino, ND; Artiles Ruano, ME; Contardi Lista, AM; García Rodríguez, AR |
| 2012-03-01 | Agreement between community pharmacy, physician's office, and home blood pressure measurement Methods : the palmera study | Sendra-Lillo, J; Sabater-Hernández, D; Sendra-Ortolá, A; Martínez-Martínez, F |
| 2012-01-01 | Effectiveness of dader method for pharmaceutical care on control of blood pressure and total cholesterol in outpatients with cardiovascular disease or cardiovascular risk: EMDADER-CV randomized controlled trial | Amariles, P; Sabater-Hernández, D; García-Jiménez, E; Rodríguez-Chamorro, MA; Prats-Más, R; Marín-Magán, F; Galán-Ceballos, JA; Jiménez-Martín, J; José Faus, M |
| 2011-09-01 | Action guide for community pharmacist in patients with hypertension and cardiovascular risk. Consensus document (condensed version). | Sabater-Hernández, D; de la Sierra, A; Bellver-Monzó, O; Divisón, JA; Gorostidi, M; Perseguer-Torregosa, Z; Segura, J; Tous, S |
| 2011-08-01 | Magnitude of the white-coat effect in the community pharmacy setting: The MEPAFAR study | Sabater-Hernández, D; De La Sierra, A; Sánchez-Villegas, P; Baena, MI; Amariles, P; Faus, MJ |
| 2011-06-01 | Evaluation of the hypertensive state in treated patients: Selection of appropriate blood pressure measurements per visit to the community pharmacy | Sabater-Hernández, D; Sánchez-Villegas, P; Lacampa, P; Artiles-Campelo, A; Jorge-Rodríguez, ME; Faus, MJ |
| 2011-06-01 | Predictors of the community pharmacy white-coat effect in treated hypertensive patients. The MEPAFAR study | Sabater-Hernández, D; Sánchez-Villegas, P; García-Corpas, JP; Amariles, P; Sendra-Lillo, J; Faus, MJ |
| 2011-05-01 | Action guide for community pharmacist in patients with hypertension and cardiovascular risk. Consensus document (condensed version) | Sabater-Hernández, D; De La Sierra, A; Bellver-Monzó, O; Divisón, JA; Gorostidi, M; Perseguer-Torregosa, Z; Segura, J; Tous, S |
| 2011-04-01 | Comparison of the white-coat effect in community pharmacy versus the physician's office: The Palmera study | Sendra-Lillo, J; Sabater-Hernández, D; Sendra-Ortolá, A; Martínez-Martínez, F |
| 2010-10-01 | Clinical value of blood pressure measurement in the community pharmacy | Sabater-Hernández, D; Azpilicueta, I; Sánchez-Villegas, P; Amariles, P; Baena, MI; Faus, MJ |
